17-beta-hydroxysteroid dehydrogenase deficiency epidemiology and demographics

17-beta-hydroxysteroid dehydrogenase deficiency Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating 17-beta-hydroxysteroid dehydrogenase deficiency from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Molecular Genetic Studies
Genotyping
X Ray
CT
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgical Therapy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
17-beta-hydroxysteroid dehydrogenase deficiency epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of 17-beta-hydroxysteroid dehydrogenase deficiency epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on 17-beta-hydroxysteroid dehydrogenase deficiency epidemiology and demographics
CDC on 17-beta-hydroxysteroid dehydrogenase deficiency epidemiology and demographics
17-beta-hydroxysteroid dehydrogenase deficiency epidemiology and demographics in the news
Blogs on 17-beta-hydroxysteroid dehydrogenase deficiency epidemiology and demographics
Directions to Hospitals Treating 17-beta-hydroxysteroid dehydrogenase deficiency
Risk calculators and risk factors for 17-beta-hydroxysteroid dehydrogenase deficiency epidemiology and demographics

Epidemiology and Demographics

In the Netherlands, 17-beta-hydroxysteroid dehydrogenase deficiency is estimated to occur 1:147.000 newborns. It is more common in Gaza populations where it affects 1 in 200 to 300 people.